NKTR-214, an Engineered Cytokine with Biased IL2 Receptor Binding, Increased Tumor Exposure, and Marked Efficacy in Mouse Tumor Models.
Clin Cancer Res
; 22(3): 680-90, 2016 Feb 01.
Article
in En
| MEDLINE
| ID: mdl-26832745
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Polyethylene Glycols
/
Recombinant Fusion Proteins
/
Prodrugs
/
Receptors, Interleukin-2
/
Interleukin-2
/
Neoplasms
/
Antineoplastic Agents
Type of study:
Prognostic_studies
Language:
En
Journal:
Clin Cancer Res
Journal subject:
NEOPLASIAS
Year:
2016
Document type:
Article
Country of publication:
Estados Unidos